Should you be buying the dip? Let's find out. The post Why did CSL shares crash 39% in 2025? appeared first on The Motley ...

A high speed run featuring the BMW M4 CSL alongside a Lamborghini STO, filmed in 4K. This video focuses on straight line ...

CSL management originally forecast revenue growth of 4-5% and net profit after tax before amortisation (NPATA) growth of 7-10 ...

Inline-six engines are the beating heart of a certain German automaker - here's the most powerful of them all.

Steven Ewing spent his childhood reading car magazines, making his career as an automotive journalist an absolute dream job. After getting his foot in the door at Automobile while he was still a ...

Macquarie Group Ltd (ASX: MQG) has downgraded CSL Ltd (ASX: CSL) shares. Let's find out why the broker has made the ...

BMW has brought back the 3.0 CSL name on a new limited-edition sports car that echoes the design of the original '70s-era 3.0 CSL and sports a motorsports-inspired livery. The twin-turbo 3.0-liter ...

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

In an effort to drum up hype for its newly released M4 CSL, BMW is revealing a bunch of never-before-seen CSL concepts to the public. Earlier this week it showed off a V-8-powered M3 CSL alongside the ...

With plasma collection as its stock-in-trade, the struggles of CSL during the coronavirus lockdown were understandable. But a rebound—fueled by a surge in post-pandemic collections and an $11.7 ...

CSL Behring’s largest-ever trial has ended in failure, as the Australian pharma revealed that its cholesterol efflux enhancer was unable to reduce the risk of heart attacks. The company had been ...

CSL Limited, a biotechnology company that produce many of its biological products from plasma, is diversifying its portfolio and its drug pipeline through its largest ever acquisition: the purchase of ...